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PXPEDITED REVIEWS
ietary Linolenic Acid and Adjusted
T and JT Intervals in the National Heart,
ung, and Blood Institute Family Heart Study
uc Djoussé, MD, DSC, MPH,* Pentti M. Rautaharju, MD, PHD,† Paul N. Hopkins, MD, MSPH,‡
ric A. Whitsel, MD, MPH,§ Donna K. Arnett, PHD, MSPH, John H. Eckfeldt, MD, PHD,¶
ichael A. Province, PHD,# R. Curtis Ellison, MD,* on behalf of the Investigators of the NHLBI
amily Heart Study
oston, Massachusetts; Winston-Salem and Chapel Hill, North Carolina; Salt Lake City, Utah; Birmingham,
labama; Minneapolis, Minnesota; and St. Louis, Missouri
OBJECTIVES The goal of this study was to examine whether higher consumption of total linolenic acid was
associated with rate-adjusted QT and JT intervals (QTrr and JTrr, respectively).
BACKGROUND Higher intake of fish omega-3 fatty acids and plant omega-3 such as alpha-linolenic acid is
associated with lower risk of myocardial infarction. While long-chain omega-3 can inhibit
ventricular arrhythmia, it is not known whether alpha-linolenic acid influences ventricular
repolarization.
METHODS We studied 3,642 subjects from the National Heart, Lung, and Blood Institute Family Heart
study who were free of myocardial infarction, left ventricular hypertrophy, pacemaker, and
with QRS 120 ms. We used the 95th percentile of the gender-specific distribution of QTrr
and JTrr to define abnormally prolonged repolarization. Within each gender, we created age-
and energy-adjusted tertiles of linolenic acid and used regression models for analyses.
RESULTS Mean age was 50 years, and average intake of total linolenic acid was 0.74 g/day. There was
an inverse association between consumption of linolenic acid and QTrr and JTrr (p for trend
0.001 and 0.0005, respectively). From the lowest (reference) to the highest gender-, age-, and
energy-adjusted tertile of linolenic acid, multivariable adjusted odds ratios for prolonged
QTrr were 1.0, 0.74 (95% confidence interval [CI] 0.57 to 0.96), and 0.59 (95% CI 0.44 to
0.77), respectively (p for trend 0.0003). Corresponding values for JTrr were 1.0, 0.73 (95% CI
0.52 to 1.03), and 0.59 (95% CI 0.40 to 0.87), respectively (p for trend 0.009). Exclusion of
subjects taking drugs known to influence QT did not influence this association.
CONCLUSIONS Higher intake of dietary linolenic acid might be associated with a reduced risk of abnormally
prolonged repolarization in men and women. (J Am Coll Cardiol 2005;45:1716–22)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.060© 2005 by the American College of Cardiology Foundation
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foronary artery disease (CAD) remains the leading cause
f death in the U.S. While several studies have demon-
trated the beneficial effects of dietary linolenic acid on
yocardial infarction (1–5), limited data are available on
ossible underlying physiologic mechanisms. Reducing
nflammation (6) and lowering triglycerides (7,8) and,
erhaps, blood pressure (9) have been suggested as
ossible pathways. The role of linolenic acid on ventric-
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nd Epidemiology, University of North Carolina, Chapel Hill, North Carolina; the
epartment of Epidemiology, University of Alabama at Birmingham, Birmingham,
labama; ¶the Department of Laboratory Medicine and Pathology, Fairview-
niversity Medical Center, Minneapolis, Minnesota; and #the Division of Biostatis-
ics, Washington University, St. Louis, Missouri. Support was partially provided by
he National Heart, Lung, and Blood Institute cooperative agreement grants U01
L56563, U01 HL56564, U01 HL56565, U01 HL56566, U01 HL56567, U01
L56568, U01 HL56569, and grant K01-HL70444.m
Manuscript received October 29, 2004; revised manuscript received December 16,
004, accepted January 11, 2005.lar repolarization in humans has not been investigated.
small percentage of linolenic acid can be converted to
ong-chain omega-3 fatty acids such as eicosapentaenoic
atty acid (EPA) and, in lesser amounts, to docosahexae-
oic acid (DHA) (10). Both EPA and DHA have been
hown to reduce the risk of sudden cardiac death, possibly
hrough antiarrhythmic effects (11,12). In an animal
odel, EPA and DHA prevented ventricular fibrillation
ompared with a control group (13). To date, no study
as investigated whether dietary linolenic acid influences
he ventricular repolarization phase in humans as mea-
ured by rate-adjusted QT and JT intervals (QTrr and
Trr, respectively) (14,15). Linoleic acid—an omega-6
atty acid— competes with linolenic acid as substrates for
esaturase and elongase enzymes. Because the Western
iet is rich in linoleic acid, it has been suggested that a
ower ratio of linoleic/linolenic acid (e.g., below 6) would
aximize the conversion of linolenic acid to DHA (16).
ietary linolenic acid in foods is predominantly alpha-
orm, and a small amount of gamma-form is found
ostly in fatty meat. Dietary linolenic acid is found
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May 17, 2005:1716–22 Dietary Linolenic Acid and QT Intervalainly in flaxseed, linseed, and canola oil, and, to a lesser
xtent, in soybean oil and green leafy vegetables (16).
We used data collected on 3,642 Caucasian participants
f the National Heart, Lung, and Blood Institute (NHLBI)
amily Heart study to assess whether dietary consumption
f higher amounts of total linolenic acid (alpha- and
amma-form) was associated with QTrr and JTrr. In
ddition, we evaluated whether such association was mod-
fied by the ratio of linoleic-to-linolenic fatty acid.
ETHODS
tudy population. Subjects in this project were partici-
ants of the NHLBI Family Heart study. A detailed
escription of the NHLBI Family Heart study has been
ublished (17). Briefly, families in the study had been
hosen randomly (a random group n  2,673) or based on
higher than expected risk of CAD from previously
stablished population-based cohort studies (a high-risk
roup n  3,037). A family risk score, which related the
amily’s age- and gender-specific incidence of CAD to that
xpected in the general population (18), was used to identify
amilies for the high-risk group. Of the 5,710 Caucasian
ubjects, we excluded 2,068 from the main analyses for the
ollowing reasons: 1) missing data on electrocardiogram
ECG) (n  21), or on dietary linolenic acid (n  827), or
ovariates (n  119); 2) unreliable food frequency question-
aire (n  149); 3) energy intake outside a priori ranges (n
140); 4) myocardial infarction (n  498) or major
entricular conduction defect (n  308); and 5) QRS
nterval above 120 ms (n  6).We did not have an adequate
ample on non-Caucasians (n  265) for separate analyses.
ach participant gave informed consent, and the study
rotocol was reviewed and approved by each of the partic-
pating institutions.
ietary assessment. We used a staff-administered semi-
uantitative food frequency questionnaire (19) to obtain
ata on dietary linolenic acid and other nutrients. The
eproducibility and validity of this food frequency question-
aire have been described previously (20). Nutrients were
btained by multiplying the frequency of consumption of an
Abbreviations and Acronyms
AA  arachidonic acid
CAD  coronary artery disease
CI  confidence interval
DHA  docosahexaenoic acid
ECG  electrocardiogram/electrocardiographic
EPA  eicosapentaenoic acid
JTrr  rate-adjusted JT interval as JT  176 · [(60/
HR)  1]  14 for men (HR  heart rate)
NHLBI  National Heart, Lung, and Blood Institute
QTc  rate-adjusted QT interval as QT/RR1/2
QTrr  rate-adjusted QT interval as QT  185 · [(60/
HR)  1]  6 for men (HR  heart rate)tem by the nutrient content of specified portions. Compo- fition values for total linolenic acid and other nutrients were
btained from the Harvard University Food Composition
atabase derived from U.S. Department of Agriculture
ources (21) and manufacturer information.
CG methodology. All ECGs in the study were recorded
sing strictly standardized methods for ECG acquisition
nd processing. These methods have been described previ-
usly (22). Briefly, during the clinic visit, standard 12-lead
CGs were recorded using MAC-PC electrocardiographs
Marquette Electronics, Inc., Milwaukee, Wisconsin), and
0-s records were digitized using a sampling rate of 250
amples/s per lead. All QT measurements were visually
erified, and occasional errors were corrected using interac-
ive graphics terminals. The QT and JT intervals were
ate-adjusted as a linear function of the RR interval using
he algorithms described by Rautaharju et al. (15): QTrr 
T  185 · (60/heart rate  1)  [6 ms in men] and JTrr
JT  176 · (60/heart rate  1)  [14 ms in men], where
T  QT  QRS. This method of adjustment eliminates
he strong residual correlation between the adjusted QT and
eart rate observed repeatedly for the Bazett’s QTc (23–25).
ther variables. Resting blood pressure was measured
hree times on sitting participants after a 5-min rest using a
andom zero sphygmomanometer by trained technicians.
nformation on cigarette smoking, alcohol intake, educa-
ion, and level of physical activity during the previous year
as obtained by interview. Diabetes mellitus was present if
subject was taking hypoglycemic agents, or if a physician
ad told him/her that he/she has diabetes mellitus, or if
asting glucose levels were above 7.0 mmol/l. Prevalent
AD was assessed by self-reported history of myocardial
nfarction, percutaneous transluminal coronary angioplasty,
r coronary artery bypass graft. Use of digoxin, diuretic,
ntiarrhythmic drugs, and other prescription drugs were
ssessed through medication inventory.
tatistical analyses. Because higher energy intake is asso-
iated with higher linolenic acid and energy intake and
ietary patterns differ between men and women and by age,
e created gender-, age-, and energy-specific tertiles of
inolenic acid. Within each gender, we created four-year age
roups (seven categories) and quintiles of energy intake.
hen, within each of the 35 groups, we created tertiles of
inolenic acid (referred to as gender-, age-, and energy-
pecific tertiles of linolenic acid). To estimate adjusted mean
alues of QTrr and JTrr, we used generalized estimating
quations to account for familial clustering and confounding
actors. The minimal adjusted model controlled for age,
ody mass index, systolic and diastolic blood pressure, and
erum potassium. The full model also controlled for diabetes
ellitus, exercise, class Ia and class III antiarrhythmic drugs,
nd other drugs known to prolong QT intervals or increase
he risk of Torsades de Pointes (i.e., antipsychotic, antima-
arial, macrolide antibiotics, opiate agonist, and so on).
urther adjustment for center, education, diuretic use, risk
roup (random vs. high-risk group), long-chain omega-3
atty acids, and waist-hip ratio did not alter the results (data
n
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Dietary Linolenic Acid and QT Interval May 17, 2005:1716–22ot shown). We also used the 95th percentile of the
ender-specific distribution of QTrr (446.9 for men and
55.0 for women) and JTrr (359.0 for men and 363.7 for
omen) to define abnormal QTrr and abnormal JTrr and
sed a generalized estimating equation to compute the
revalence odds ratios. In addition, we used linolenic acid as
continuous variable and related it to QTrr and JTrr. We
onducted sensitivity analyses by: 1) excluding subjects who
ere using digoxin or antiarrhythmic drugs; and 2) using
ubjects previously excluded in the initial analyses. Because
inoleic and linolenic acids are competitive substrate for
esaturase, we assessed whether the linoleic/linolenic ratio
odified the association through: 1) stratified analyses using
ender-specific median values of linolenic acid to create two
roups; and 2) including main effects and product term in
he regression model. Alpha level was set at 0.05, and all
nalyses were completed using windows SAS version 5.1.2,
elease 8.02 (SAS Institute, Cary, North Carolina).
ESULTS
haracteristics of participants. Of the 3,642 Caucasian
articipants included in the analyses, 1,477 were men and
,165 were women. The mean age was 48.6 13.4 years for
en and 51.1  13.4 years for women. The average daily
able 1. Characteristics of the 3,642 Participants of the NHLBI
nergy-Adjusted Tertiles of Dietary Linolenic Acid*
Characteristics
Te
Men
1 (Low)
[0.58]
(n  484)
2
[0.78]
(n  501)
ge (yrs) 47.8  13.6 49.2  13.3
ody mass index (kg/m2) 27.2  4.2 27.8  4.5
aist-hip ratio 0.95  0.08 0.96  0.07
HA  EPA (g) 0.23  0.22 0.24  0.25
inoleic/linolenic ratio 11.9  4.4 10.6  3.3
nergy intake (KJ) 7,764  2,532 8,041  2,627
lood pressure
Diastolic (mm Hg) 71.5  10.3 72.1  9.2
Systolic (mm Hg) 118.5  15.9 118.5  15.3
otassium (mmol/l) 4.2  0.33 4.3  0.30
xercise (min/day) 38.4  47.8 34.2  38.3
andom sample (%) 52.5 54.7
ntiarrhythmic drug class
Ia or II (%)
1.5 1.0
igoxin use (%) 1.5 1.4
se of non-potassium sparing
diuretic (%)
3.5 2.4
se of other drugs known to
prolong QT interval (%)
1.2 1.2
ducation (%)
High school 26.0 27.9
Some college 9.1 12.0
College graduate 64.9 60.1
ypertension (%) 13.6 13.0
iabetes mellitus (%) 2.1 4.6Values expressed as mean  SD, unless specified otherwise.
DHA  docosahexaenoic acid; EPA  eicosapentaenoic acid; NHLBI  National Heonsumption of total dietary linolenic acid was 0.81 
.35 g for men (range 0.21 to 3.48 g/day) and 0.69 0.29 g
or women (range 0.13 to 2.45 g/day). Table 1 presents the
aseline characteristics by gender-, age-, and energy-
djusted tertiles of dietary linolenic acid.
ssociation between dietary linolenic acid and QTrr and
Trr intervals. Dietary linolenic acid was inversely associ-
ted with QTrr in men in a multivariable adjusted model (p
or linear trend 0.0009) (Table 2). In women, a nonstatis-
ically significant inverse association between dietary linole-
ic acid and QTrr was observed (p for trend 0.12) (Table 2).
n a multivariable model, both men and women showed an
nverse association between linolenic acid and JTrr in a
ose-response fashion (p for linear trend 0.002 for men and
.04 for women) (Table 2). We observed a similar associa-
ion using dietary linolenic acid as a continuous variable. For
en and women combined, the regression coefficients (SE)
or QTrr were 0.5479 (0.1888) for the crude model and
0.835 (0.3061) for the multivariate-adjusted regression
odel. Corresponding values for JTrr were 0.4945
0.2437) for the crude and 0.9994 (0.4224) for the
ultivariable model.
There was evidence for a reduced risk for the prolonged
epolarization in both men and women. From the lowest to
ily Heart Study According to Gender-, Age-, and
of Linolenic Acid [Median, g/day]
Women
3 (High)
[0.96]
n  492)
1 (Low)
[0.50]
(n  708)
2
[0.64]
(n  749)
3 (High)
[0.85]
(n  708)
8.9  13.2 50.6  13.7 51.4  13.3 51.3  13.2
8.0  4.8 26.5  5.7 27.1  6.0 27.6  6.6
.95  0.07 0.87  0.10 0.87  0.09 0.88  0.09
.21  0.17 0.21  0.19 0.25  0.24 0.22  0.20
9.4  2.8 11.6  5.2 10.0  3.4 8.7  2.6
38  3,082 6,576  2,173 6,728  2,249 7,040  2,447
1.6  9.9 66.1  9.7 67.1  9.7 67.7  9.5
7.1  15.4 113.0  17.6 113.1  17.4 114.1  18.0
4.3  0.3 4.1  0.3 4.1  0.3 4.1  0.3
4.4  41.2 27.5  35.0 24.1  32.1 21.9  29.9
52.2 47.7 48.7 48.7
1.6 2.4 3.5 2.7
0.6 1.4 0.7 1.3
2.6 4.1 5.1 5.5
1.6 1.1 1.5 2.5
28.8 34.2 36.2 43.0
13.1 14.7 12.8 10.6
58.1 51.1 51.1 46.4
11.2 11.3 11.3 12.0
5.5 3.5 5.6 4.5Fam
rtiles
(
4
2
0
0
8,4
7
11
3art, Lung, and Blood Institute.
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May 17, 2005:1716–22 Dietary Linolenic Acid and QT Intervalhe highest tertile of linolenic acid, multivariable adjusted
revalence odds ratios for prolonged repolarization based on
Trr were 1.0 (reference), 0.81 (95% confidence intervals
CI] 0.46 to 1.44), and 0.51 (95% CI 0.27 to 0.98),
espectively, for men (p for trend 0.04) (Table 3). Corre-
ponding values for women were 1.0, 0.71 (95% CI 0.53 to
0.95), and 0.60 (95% CI 0.44 to 0.82), respectively (p for
rend 0.003) (Table 3). Similar reduced risk of prolonged
epolarization using JTrr was observed, and the results were
tronger in women than in men (Table 4). In both men and
omen combined, the risk of abnormally prolonged repo-
arization was 41% lower in the highest tertile of linolenic
able 2. Crude and Adjusted Mean Values  SE of the Rate-Ad
inolenic Acid in 3,642 Participants of the NHLBI Family Hear
Age- and Energy-Adjusted Tertiles
of Dietary Linolenic Acid [Median] n
Mean 
Crude M
en
1 [0.58 g/day] (low) 484 418.5  0.9 41
2 [0.78 g/day] 501 417.0  0.8 41
3 [0.96 g/day] (high) 492 415.6  0.9 41
p value for linear trend 0.02
omen
1 [0.50 g/day] (low) 708 424.7  0.7 42
2 [0.64 g/day] 749 424.6  0.7 42
3 [0.85 g/day] (high) 708 424.1  0.7 42
p value for linear trend 0.52
en and women combined
1 [0.53 g/day] (low) 1,192 422.2  0.6 42
2 [0.69 g/day] 1,250 421.6  0.6 42
3 [0.89 g/day] (high) 1,200 420.6  0.6 42
p value for linear trend 0.04
Trr  QT  185 · [(60/HR)  1]  6 for men and QT  185 · [(60/HR)  1]
T  176 · [(60/HR)  1] for women. *Adjusted for age, body mass index, systolic an
iabetes mellitus, physical activity, class Ia and class III anti-arrhythmic drugs, and o
JTrr  rate-adjusted JT interval; NHBLI  National Heart, Lung, and Blood I
able 3. Crude and Adjusted Odds Ratios (95% Confidence Inte
nd Energy-Adjusted Tertiles of Dietary Linolenic Acid in 3,642 Pa
Age- and Energy-Adjusted Tertiles
of Dietary Linolenic Acid [Median] Cases/n
en
1 [0.58 g/day] (low) 30/484
2 [0.78 g/day] 27/501
3 [0.96 g/day] (high) 17/492
p value for linear trend
omen
1 [0.50 g/day] (low) 120/708
2 [0.64 g/day] 102/749
3 [0.85 g/day] (high) 88/708
p value for linear trend
en and women combined
1 [0.53 g/day] (low) 150/1,192
2 [0.69 g/day] 129/1,250
3 [0.89 g/day] (high) 105/1,200
p value for linear trend
Trr  QT  185 · [(60/HR)  1]  6 for men and QT  85 · [(60/HR)  1] fo
5th percentile of the gender-specific distribution. †Adjusted for age, body mass ind
nergy intake, diabetes mellitus, physical activity, class Ia and class III anti-arrhythmi
or gender.
CI  confidence interval; OR  odds ratio; other abbreviations as in Table 2.cid compared with the lowest tertile in a multivariable
djusted model (Table 4).
The ratio of linoleic-to-linolenic acid did not influence
he results, and there was no evidence for interaction
etween linoleic and linolenic acid on abnormal QTrr (p 
.21) or JTrr (p  0.23).
ensitivity analyses. Exclusion of subjects currently receiv-
ng digoxin and/or antiarrhytmic drugs did not change the
esults. From the lowest to the highest tertile of linolenic
cid, multivariable adjusted odds ratios for prolonged repo-
arization using QTrr in the combined data set were 1.0
reference), 0.75 (95% CI 0.57 to 0.98), and 0.61 (95% CI
d QT and JT Intervals by Gender and Tertiles of Dietary
dy
of QTrr Mean  SE of JTrr
1* Model 2† Crude Model 1* Model 2†
0.8 419.1  0.8 328.2  0.9 328.7  0.9 328.8  0.9
0.8 416.8  0.8 327.0  0.9 326.7  0.8 326.7  0.9
0.8 415.2  0.8 325.5  0.9 325.2  0.9 325.1  0.9
0.0009 0.03 0.005 0.002
0.7 425.3  0.7 333.8  0.8 334.1  0.7 334.3  0.7
0.7 424.4  0.7 332.9  0.7 332.7  0.7 332.7  0.7
0.7 423.7  0.7 332.3  0.8 332.1  0.7 332.1  0.7
0.12 0.15 0.05 0.04
0.5 422.8  0.5 331.5  0.6 331.9  0.6 332.1  0.6
0.5 421.3  0.5 330.5  0.6 330.3  0.5 330.3  0.5
0.5 420.3  0.5 329.5  0.6 329.4  0.6 329.3  0.6
0.001 0.013 0.002 0.0005
men, where HR is heart rate. JTrr  JT  176 · [(60/HR)  1]  14 for men and
tolic blood pressure, and serum potassium. †Additional adjustment for energy intake,
rugs known to prolong QT intervals. The combined group also adjusts for gender.
e; QTrr  rate-adjusted QT interval.
) for Abnormal Rate-Adjusted QT According to Gender-, Age-,
ants of the NHLBI Family Heart Study*
OR (95% CI) for Abnormal QTrr
Crude Model 1† Model 2‡
1.0 1.0 1.0
(0.50–1.50) 0.81 (0.46–1.42) 0.81 (0.46–1.44)
(0.29–1.02) 0.50 (0.26–0.94) 0.51 (0.27–0.98)
0.06 0.03 0.04
1.0 1.0 1.0
(0.58–1.03) 0.72 (0.54–0.97) 0.71 (0.53–0.95)
(0.51–0.94) 0.63 (0.46–0.86) 0.60 (0.44–0.82)
0.02 0.005 0.003
1.0 1.0 1.0
(0.62–1.03) 0.75 (0.58–0.98) 0.74 (0.57–0.96)
(0.51–0.87) 0.61 (0.46–0.81) 0.59 (0.44–0.78)
0.004 0.005 0.0003
en, where HR is heart rate. *Abnormal QTrr is defined as a QTrr value greater than
tolic and diastolic blood pressure, and serum potassium. ‡Additional adjustment for
s, and other drugs known to prolong QT intervals. The combined group also adjustsjuste
t Stu
SE
odel
9.0 
6.8 
5.3 
0.002
5.2 
4.4 
3.8 
0.18
2.6 
1.4 
0.4 
0.005
for wo
d diasrvals
rticip
0.86
0.54
0.77
0.69
0.80
0.67
r wom
ex, sys
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Dietary Linolenic Acid and QT Interval May 17, 2005:1716–22.45 to 0.82), respectively (p for trend 0.0012). Correspond-
ng values were 1.0, 0.64 (95% CI 0.45 to 0.91), and 0.53
95% CI 0.35 to 0.80), respectively, using JTrr (p for trend
.003). In a sample (n  4,504) that included subjects
xcluded in the initial analyses (i.e., prevalent CAD, left
entricular hypertrophy, and so on), the observed associa-
ion persisted (i.e., p for trend 0.0017 using QTrr to define
bnormal repolarization), and further adjustment for left
entricular hypertrophy, T-negativity, ST-segment depres-
ion/elevation did not change the results.
ISCUSSION
n this cross-sectional study, higher intake of dietary total
inolenic acid (alpha- and gamma-form) was inversely asso-
iated with heart-rate–adjusted QT and JT intervals in a
ose-response manner in both men and women. This
ssociation was not modified by the ratio of n-6 to n-3 fatty
cids.
-3 fatty acids and arrhythmia. While epidemiologic
tudies have shown the beneficial effects of linolenic acid on
atal and nonfatal CAD (1–5), triglycerides (8), and carotid
all thickness (26), no data are available on the effects of
inolenic acid on myocardial repolarization in humans.
vidence of beneficial effects of EPA and DHA on ven-
ricular arrhythmia has been shown in animal models and in
umans. Infusion of EPA (12,13), DHA (12,13), and
lpha-linolenic acid (12) in dogs was associated with a
ignificant reduction in ventricular fibrillation. Rats fed with
tuna fish oil diet had a significantly lower incidence rate
nd severity of arrhythmias and lower risk of ventricular
brillation compared with rats on a diet enriched with
unflower oil (27). In a study of monkeys, fish oil was
ssociated with significantly raised ventricular fibrillation
able 4. Crude and Adjusted Odds Ratios (95% Confidence Inte
nergy-Adjusted Tertiles of Dietary Linolenic Acid in 3,642 Par
Age- and Energy-Adjusted Tertiles
of Dietary Linolenic Acid [Median] Cases/n
en
1 [0.58 g/day] (low) 29/484
2 [0.78 g/day] 24/501
3 [0.96 g/day] (high) 20/492
p value for linear trend
omen
1 [0.50 g/day] (low) 45/708
2 [0.64 g/day] 36/749
3 [0.85 g/day] (high) 27/708
p value for linear trend
en and women combined
1 [0.53 g/day] (low) 74/1,192
2 [0.69 g/day] 60/1,250
3 [0.89 g/day] (high) 47/1,200
p value for linear trend
Trr  JT  176 · [(60/HR)  1]  14 for men and JT  176 · [(60/HR)  1] for
5th percentile of the gender-specific distribution. †Adjusted for age, body mass ind
nergy intake, diabetes mellitus, physical activity, class Ia and class III anti-arrhythmi
or gender.
Abbreviations as in Tables 2 and 3.hreshold (33.3 mA) compared with sunflower oil (14.3 fA) after a 16-week intervention (28). Siscovick et al. (29)
emonstrated that, compared with no intake of dietary EPA
nd DHA, monthly intake of 5.5 g of n-3 fatty acid was
ssociated with a 50% reduction in the risk of primary
ardiac arrest in 334 patients. In a randomized control trial,
diet rich in EPA and DHA was associated with a 48%
ecrease in ventricular premature complexes compared to
nly 25% reduction in the placebo group (sunflower oil)
fter 16 weeks of intervention (30). Nevertheless, little is
nown about the relation between dietary linolenic acid and
entricular repolarization or arrhythmia. The only evidence
howing antiarrhythmic effects of alpha-linolenic acid has
een provided from animal study. In a dog model of cardiac
udden death, alpha-linolenic acid infusion prevented fatal
entricular fibrillation in six of eight dogs (12), an effect
imilar to infusion of DHA or EPA in the same study. To
ur knowledge, no previous study has examined the relation
etween dietary linolenic acid and heart-rate–adjusted QT
r JT intervals.
hysiologic mechanisms. Modification of the eicosanoid
ystem by dietary fatty acids is one of the suggested
echanisms by which EPA and DHA protect against
entricular arrhythmia. The Western diet is rich in linoleic
cid, which is a precursor of arachidonic acid (AA); AA is
etabolized to generate (n-2) series of prostanoids such as
hromboxane A2 and leukotrienes. Alpha-linolenic acid is a
recursor of prostaglandin I3 (a vasodilator) and thrombox-
ne A3, which is less active (9). A limited amount of
inolenic acid is converted to EPA in vivo; EPA competes
ith AA as a substrate for cyclooxygenase, thus inhibiting
he production of thromboxane A2 that causes vasoconstric-
or and platelet aggregation. A reduced ratio of AA/EPA
) for Abnormal Rate-Adjusted JT by Gender-, Age-, and
nts of the NHLBI Family Heart Study*
OR (95% CI) for Abnormal JTrr
Crude Model 1† Model 2‡
1.0 1.0 1.0
(0.45–1.38) 0.77 (0.44–1.36) 0.77 (0.44–1.36)
(0.36–1.20) 0.68 (0.37–1.25) 0.68 (0.36–1.27)
0.18 0.21 0.22
1.0 1.0 1.0
(0.49–1.35) 0.71 (0.46–1.08) 0.70 (0.46–1.08)
(0.35–0.96) 0.54 (0.32–0.90) 0.53 (0.32–0.89)
0.04 0.02 0.02
1.0 1.0 1.0
(0.54–1.07) 0.73 (0.52–1.03) 0.73 (0.52–1.03)
(0.42–0.90) 0.59 (0.40–0.88) 0.59 (0.40–0.87)
0.014 0.009 0.009
n; where HR is heart rate. *Abnormal QTrr is defined as a QTrr value greater than
tolic and diastolic blood pressure, and serum potassium. ‡Additional adjustment for
s, and other drugs known to prolong QT intervals. The combined group also adjustsrvals
ticipa
0.79
0.66
0.74
0.58
0.76
0.62
wome
ex, sys
c drugavors the production of (n-3) series of prostanoids and less
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May 17, 2005:1716–22 Dietary Linolenic Acid and QT Intervalhromboxane A2 and, thus, reduces the risk of ventricular
brillation and cardiac arrest (31). Another possible mech-
nism is the modulation of L-type calcium channels in the
arcolemma of cardiac myocytes by DHA (32). However,
dditional research is needed to elucidate biologic mecha-
isms underlying antiarrhythmic effects of n-3 fatty acids.
Other investigators have suggested that a diet rich in n-3
atty acids (such as linolenic acid) could suppress plasma
evels of metabolites of linoleic acid such as thromboxane
2, which stimulates vasoconstriction and platelet aggrega-
ion (33). This has been the basis to favor a lower ratio of
inoleic-to-linolenic acid (below 6). In the present study, the
ssociation between linolenic acid and QT intervals was not
odified by the ratio of linoleic-to-linolenic acid.
tudy limitations. In the present study, nutrients were
erived from a food frequency questionnaire that has been
hown to underestimate energy intake when compared with
he doubly-labeled water technique (34). Therefore, our
stimate of daily intake of linolenic acid and other nutrients
ight have been biased. We did not have data separately on
lpha- and gamma-linolenic acid. In addition, the cross-
ectional design of our study limits our ability to infer
ausality between linolenic acid intake and QT/JT. How-
ver, the large sample size, the availability of data on several
isk factors, the wide range of age and linolenic acid, the
onsistency of our findings with other published reports,
nd the multicenter design are strengths of our study.
In conclusion, our data suggest that higher consumption
f dietary linolenic acid is associated with a reduced risk of
rolonged repolarization in both men and women. While
his might be one of the underlying mechanisms by which
ietary linolenic acid decrease the risk of cardiovascular
isease, future studies are needed to confirm our findings.
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